Speckle-type poz protein (SPOP) is an E3-ubiquitin ligase adaptor for turnover of a diverse number of proteins involved in key cellular processes such as chromatin remodeling, transcriptional regulation, and cell signaling. Genomic analysis revealed that SPOP somatic mutations are found in a subset of endometrial cancers, suggesting that these mutations act as oncogenic drivers of this gynecologic malignancy. These studies also raise the question as to the role of wild-type SPOP in normal uterine function. To address this question, we generated a mouse model ( 
Introduction
Efforts to improve diagnosis and treatment of uterine dysfunction are stymied by an incomplete understanding of the key endometrial molecular signals that are required for early establishment of the maternofetal interface. Recent whole exome sequencing has revealed that speckle-type poz (pox virus and zinc finger) protein (SPOP; also known as PCIF1 [1] ) is frequently mutated in human endometrial cancers [2] [3] [4] [5] . This observation suggests that SPOP mutations may act as oncogenic drivers of this gynecological malignancy and raises the question: Is wild-type SPOP required for normal uterine biology? Acting as a 42 kDa adaptor protein for the cullin3 (CUL3)-based E3 ubiquitin ligase complex, SPOP is composed of a N-terminal MATH domain, which selectively recruits substrates for ubiquitination and subsequent proteasomal degradation (reviewed in [6, 7] ). To date, all human endometrial cancer-associated SPOP mutations have been mapped to the MATH substrate-recognition cleft [7] ; therefore, such mutations are predicted to block normal substrate recruitment for proteasomal turnover. Toward the C-terminus, the bric-a-brac/tramtrack/broad (BTB) domain of SPOP is required for interaction with the CUL3 scaffold protein [6, 7] , which then targets substrates for ubiquitin-mediated degradation by the 26S proteasome.
Underscoring its evolutionary conserved and pleiotropic role in proteome homeostasis, SPOP is associated with the ubiquitination and degradation of a rapidly expanding list of diverse substrates involved in a broad spectrum of physiological processes. Some of these substrates include Daxx, the death-associated protein; Puckered (Puc), a signaling phosphatase; MacroH2A, a core histone variant; Gli (glioma associated oncogene), a transcriptional regulator; CHOP (C/EBP homologous protein), a transcription factor; CDC20 (cell division cycle 20), a cell cycle regulator; ERG (ETS-related gene), an ETS transcription factor family member; AR (androgen receptor), a nuclear transcription factor; coactivators: steroid receptor coactivator-3 (SRC-3) and tripartite motif containing 24 (TRIM 24) , and more recently c-MYC [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Although wild-type SPOP is considered a tumor suppressor in a number of human cancers (reviewed in [7] ), high expression levels of wild-type SPOP have been shown to act as a tumor promoter in other target tissues such as the kidney [21] [22] [23] [24] . These paradoxical findings may be explained in part by the cell-type specific make-up of a given SPOP substrate population, which may constitute either a majority of tumor suppressors or tumor promoters depending on cellular context [7] .
Although there is compelling evidence that mutations of SPOP may drive endometrial cancer, the in vivo role of wild-type SPOP in normal uterine function is not known. To address this issue, we recently applied conditional genetic technology in the mouse to selectively abrogate SPOP expression in uterine cells that express the PGR. Our data strongly support an important role for SPOP in normal uterine function in the mouse by regulating the homeostasis of key signaling cues required for embryo implantation and endometrial decidualization.
Materials and methods

Generation of a Spop conditional knockout mouse
As described previously [13, 25] Figure 1A and B). The PCR primer sequences to genotype the Spop f/f allele are as follows:
forward-primer 5 -GCAGAAGCAGGCAGATCTTT-3 and reverseprimer 5 -GCCCTTAGTTTTTCATGATGG-3 , which generates a 179-bp and 397-bp amplicon (PCR-2; Figure 1A housed with proven stud/breeder C57BL/6 males. Over a 6-month breeding period, the date of pup delivery, the number of litters, and the number of pups per litter were recorded for each female. For timed pregnancy studies, females were housed with fertility-proven C57BL/6 males overnight. The detection of a copulatory (or vaginal) plug the following morning was designated as day 1 of pregnancy (1 dpc); pregnant females were individually housed. To locate incipient implantation sites in uterine horns of 5-dpc pregnant dams, Chicago sky blue dye (1%; 100 μl PBS/mouse) was injected into one of the two lateral tail veins before mice were euthanized 2 min later.
To induce superovulation, 21-day old female mice were intraperitoneally (IP) injected with pregnant mare serum gonadotropin (PMSG; Sigma-Aldrich, St. Louis, MO (5 international units (IU)/100 μl of sterile 0.9% saline)). Forty-eight hours later, mice received an IP injection of human chorionic gonadotropin (hCG; Sigma-Aldrich (5 IU/100 μl of sterile 0.9% saline)). Sixteen hours post-hCG injection, oocytes were collected from oviducts and counted using a dissecting microscope as previously described [28]. Ovaries were fixed in 4% paraformaldehyde (PFA) for histological analysis. To assess ovarian cyclicity, the estrous cycle was monitored over 3-4 weeks by examining the cytology of daily vaginal lavages on slides stained with 10% crystal violet (Sigma-Aldrich) [29] .
To measure circulating serum levels of E2 and P4, blood was collected from the orbital sinus of anesthetized 5-dpc Artificial decidual response assay and hormone treatments
Elicitation of an artificial decidual response has been described [28, 30] . Briefly, mice were ovariectomized at 6 weeks of age and rested for 2 weeks before receiving three daily subcutaneous (sc) injections of E2 (100 ng). Following 2 days of rest, mice were administered three daily sc injections of E2 plus P4 (E2 (6.7 ng) and P4 (1 mg)). Six hours following the third E2P4 injection, sesame oil (50 μl) was instilled into the lumen of the left uterine horn (stimulated); the right horn did not receive oil (unstimulated). After intraluminal instillation of the deciduogenic stimulus, mice received daily sc injections of E2P4 for 5 days, and then weighed before euthanasia. Trimmed of mesometrial membrane and vasculature, extracted stimulated and unstimulated uterine horns from each mouse were weighed for wet-weight measurements before further analysis.
To assay the ability of P4 to suppress E2 induced uterine epithelial proliferation in the ovariectomized mouse, an established protocol with modifications was used [28] . Briefly, mice were ovariectomized at 6 weeks of age, rested for 2 weeks before injection with (1) 100 μl of hormone vehicle (sesame oil; termed untreated); (2) E2 (100 ng/100 μl) for 18 h; or (3) E2 (100 ng/100 μl) and P4 (1 mg/100 μl) for 24 h before euthanasia. Tissues were immediately removed for histological examination.
Immunohistochemical analyses
Tissues, fixed in 4% PFA overnight, were processed and embedded in paraffin as previously reported [28] . Tissue sections from serially sectioned tissue blocks were placed on Superfrost plus glass slides (Fisher Scientific, Pittsburgh, PA). Prior to immunohistochemical analysis, sections were deparaffinized, rehydrated, and processed through an antigen unmasking step. Following a 1-h blocking step at room temperature, tissue sections were incubated with one of the appropriate antibodies listed in Supplementary Table S1 overnight at 4
• C. After primary antibody incubation, sections were incubated with a goat anti-rabbit IgG secondary antibody (Vector laboratories Inc.) for 1 h at room temperature followed by incubation with the R.T.U Vectastain R Universal ABC reagent (Vector laboratories Inc.) for 30 min at room temperature. Immunopositivity was visualized in situ through incubation with 3, 3 -diaminobenzidine (DAB, Vector laboratories Inc.); slides were counterstained with hematoxylin for contrast. Finally, sections were dehydrated before coverslips were mounted using slowfade mounting medium (Fisher Scientific Inc.). For 5 -bromo-2 -deoxyuridine (BrdU) immunohistochemical analysis, mice were first IP injected with BrdU (10 mg/ml; Amersham Biosciences Corporation, Piscataway, NJ (0.1 ml/10 g body weight)) 2 h before euthanasia. Following tissue processing as described above, tissue sections were incubated with a biotinylated anti-BrdU antibody (BrdU In-Situ Detection Kit (BD Pharmingen Inc., San Jose, CA; 1:10 dilution)) overnight at room temperature. Sections were then incubated with the Vectastain ABC reagent at room temperature for 1 h and the immunoreaction was visualized using the DAB peroxidase substrate kit and subsequently processed as described above.
Raw images of immunostained tissue sections were digitally captured using a color chilled AxioCam MRc5 digital camera interfaced with a Carl Zeiss AxioImager A1 upright microscope (Zeiss, Jena, Germany). Postprocessing, collation, and annotation of images were performed with Photoshop and Illustrator (version 6) software programs (Adobe Systems Inc., San Jose, CA).
Molecular analyses
For studies using quantitative real-time PCR, total RNA was extracted from homogenized tissues using TRIzol R reagent (ThermoFischer Scientific Inc., Waltham, MA) and further purified using the RNeasy R Plus Mini Kit (Qiagen). Reverse transcription of total RNA into cDNA was performed using the Superscript IV VILO Master Mix (ThermoFisher Scientific Inc.) before real-time PCR amplification. Details on TaqMan R gene expression assays used in these studies are provided in Supplementary Table S2 ; the 18S ribosomal RNA TaqMan R assay was used as an internal control. To evaluate Spop transcript levels by real-time PCR, the Sensi-FAST SYBR R Hi-ROX One-Step kit (Bioline Inc., #BIO-82005) was used. The sequences of the PCR primers in the 5 -3 reaction are as follows: Spop forward primer: GGAGGAAATGGGTGAAGTCAT; Spop reverse primer: GGGTTTACTCGCAAACACCA; β-actin forward primer: GTGGTACGACCAGAGGCATAC; and β-actin reverse primer: AAGGCCAACCGTGAAAAGAT.
Conditions for western immunoblotting have been described previously [31] ; the primary antibodies used in these studies are listed in Supplementary Table S1 . The SuperSignal West Pico Chemiluminescent Substrate kit (ThermoFisher Scientific) was used to detect the chemiluminescent signal. To facilitate the re-probing of western blots with different antibodies when required, immunoblots were stripped of primary and secondary antibodies using Restore Western Blot Stripping buffer ((#21059) Thermo Fisher Scientific Inc.).
Statistical analyses
When applicable, two-tailed Student t tests along with one-way ANOVA with Tukey post hoc multiple range tests were performed using the GraphPad Prism and Instat tools (GraphPad Software Inc., La Jolla, CA). A P-value < 0.05 was considered statistically significant; asterisks in figures denote the level of significance:
* P < 0.05; * * P < 0.01; and * * * P < 0.001.
Results
The
Spop d/d female mouse is infertile
Because whole body abrogation of SPOP expression in the mouse results in early neonatal death [1, 13, 25] , we used a recently engineered mouse (the Spop f/f mouse) in which critical exons (encoding the MATH domain [7] ) of the Spop gene are flanked (or floxed) by loxP sites to allow for tissue selective ablation of SPOP with a cre driver of choice ( Figure 1A and B). The Spop f/f mouse was recently used by our colleague, Dr Nicholas Mitsiades at Baylor College of Medicine, to successfully abrogate SPOP in the prostate epithelium using the probasin-cre driver mouse [13] . Crossing the Spop f/f mouse with our Pgr-cre mouse [27] to generate the Spop
bigenic ( Figure 1A and B) , we similarly demonstrated that uterine Spop transcript levels are significantly reduced in the Spop d/d uterus ( Figure 1C) ; importantly, western analysis did not detect SPOP protein in the Spop d/d uterus ( Figure 1D ). Unfortunately, we and others [13] have not been able to find a commercial SPOP antibody suitable for immunohistochemistry on adult murine tissues. Irrespective, numerous studies have shown that the Pgr-cre driver can successfully ablate gene expression in PGR-positive cells of the murine uterus (reviewed in [32] attachment to the luminal epithelial compartment of the 5-dpc control uterus; however, embryo attachment was not observed in the 5-dpc or 6-dpc Spop d/d uterus ( Figure 2B ). In all cases, embryos were found floating in the luminal space of the Spop d/d uterus with no evidence of local luminal cavity closure around the embryo (Figure 2B) . At 5 dpc, there was no significant difference in the serum levels of P4 and E2 in Spop d/d and control mice (P4 levels (ng/ml):
.0 ± 2.5; control = 22.9 ± 2.0; and E2 levels (pg/ml):
.0 ± 0.6; control = 3.6 ± 0.6; n = 6 mice per group)).
These results show that ovarian luteal function is normal in the Spop d/d mouse during this period and concur with ovarian data presented in Supplementary Figure S1 . Figure 3 ). Using an E2 and P4 administration regimen shown in Figure 3A , we found that the Spop d/d uterine horn does not develop into a typical deciduoma following intraluminal instillation of sesame oil, which was the deciduogenic stimulus used in these experiments ( Figure 3B-H) . This result strongly supports a critical role for SPOP in steroid hormone-dependent endometrial stromal decidualization, a cellular process that is essential for the early establishment of pregnancy.
The Spop d/d infertility phenotype is intrinsic to the uterus
The expression level of PGR is markedly reduced in the murine Spop d/d uterus
Of the key uterine molecular signaling cues examined by western analysis, our first line of molecular investigations revealed that the expression level of both isoforms of PGR protein is markedly decreased in Spop d/d uteri as compared to control uteri of virgin mice ( Figure 4A ). This finding was unexpected as one study using cultured human breast cancer cells showed that PGR protein is targeted for turnover by SPOP [33] , suggesting absence of SPOP would lead to an increase (rather than a decrease) in the levels of uterine PGR. However, real-time PCR analysis demonstrated that Pgr transcript levels are also reduced by SPOP silencing (Figure 4B Figure S2) . The expression levels of steroid receptor coactivator 3 (SRC-3) are unchanged between genotypes ( Figure 4A ). Apart from their importance in murine uterine function [34, 35] , ESR1 and SRC-3 have been shown to be targets of SPOP in vitro [8, 36] as well as substrates for other ubiquitinmediated mechanisms of protein turnover [34] . We also detected a moderate increase in protein levels of GATA2 and SRC-2 in the Spop d/d uterus as compared to the control uterus (Supplementary Figure S3) ; importantly, these proteins exert important roles in endometrial responsiveness to P4 [29, 37, 38] . PGR expression in uterine sections derived from untreated ovariectomized Spop d/d and control mice ( Figure 4C-F) . It is known that PGR protein expression is markedly robust and consistent in the epithelial compartment of the uterus of the ovariectomized wild-type mouse [38] , making for an ideal model to compare the relative expression levels of this nuclear receptor in control and mutant mice by immunohistochemistry [38] . Importantly, as a consequence of the reduction of uterine PGR levels, the transcriptional induction of a number of PGR molecular targets is significantly attenuated in the Spop d/d uterus ( Figure 5 ), a subset of these targets are critical for embryo implantation [39] [40] [41] and endometrial stromal cell decidualization [31, 42] . Reduction in PGR levels in the Spop d/d uterus also results in a significant attenuation in the ability of P4 to suppress E2-induced uterine epithelial proliferation ( Figure 6 ). This result is significant as endometrial P4 resistance is linked to a number of endometrial pathologies, including endometriosis and endometrial cancer [43] . Figure 8F and G); this cellular distribution pattern has been reported for similar uterine pathologies with dilated cystic uterine glands [45] . Therefore, the Spop d/d uterine histopathology that emerges with age may arise from these foci of hyperproliferation.
Cystic endometrial glands develop in the
Discussion
Although SPOP was discovered over two decades ago [46] , conditional SPOP knockout mouse models have only been generated and characterized within the last two years [13, 25] . In the case of the murine prostate, SPOP ablation in the epithelium results in hyperplasia and dysplasia that develops into prostatic intraepithelial neoplasia (PIN) in the dorsolateral and ventral prostate by 38 weeks of age [13] . Using a similar approach that allows for the targeted ablation of SPOP in cells which express PGR, we demonstrate the importance of uterine SPOP for embryo implantation and endometrial decidualization. By revealing a critical role for SPOP in hormone-dependent endometrial decidualization, we provide essential in vivo support for recent in vitro studies [47] that report a pivotal involvement for murine SPOP in endometrial stromal cell decidualization in culture. Intriguingly, our molecular analysis demonstrates that the expression levels of both isoforms of the PGR protein are significantly attenuated with uterine SPOP depletion, providing one mechanistic explanation for the uterine dysfunction displayed by the Spop
mice. The marked reduction in PGR protein levels following SPOP ablation was unexpected since SPOP has been shown by in vitro studies to turnover PGR [33] as well as other nuclear receptors, such as ESR1 and the AR [9, 36, 48, 49] . Moreover, a recent in vivo studyusing a similar engineered mouse approach-showed that the expression levels of AR-a close relative of PGR-are markedly increased as expected in the prostate epithelium following conditional SPOP ablation in the mouse [13] . However, the observation that Pgr transcript levels are also reduced in the Spop d/d uterus argues for an indirect regulation of PGR protein levels by SPOP. Instead, these findings suggest other regulatory factors of PGR protein stability and/or transcription are substrates for uterine SPOP. Accordingly, the striking reduction in uterine PGR expression levels results in adverse molecular repercussions in terms of a significant attenuated induction of key downstream transcriptional programs required for endometrial implantation processes and decidualization in the mouse. Furthermore, the P4 resistance phenotype of the Spop d/d uterus may suggest a cellular mechanism to explain the functional defects of this tissue, when SPOP function is derailed. The latter proposal will be a major focus for future investigations. Further molecular analysis disclosed that SPOP ablation results in a moderate increase in the expression levels of uterine ESR1, GATA2, and SRC-2, suggesting that perturbation of SPOP action most likely derails the normal homeostatic levels of many proteins in the proteome required for uterine function. Although the changes in expression levels are moderate for a given protein, we speculate that the collective alterations in levels of many proteins are expected to exert significant adverse effects on uterine function. Interestingly, we have recently shown that GATA2 is required for maintaining uterine PGR expression levels [38] . The observation that GATA2 is moderately increased in the Spop d/d uterus may represent a molecular mechanism to increase PGR expression in response to the significant decrease in PGR expression levels as result of SPOP ablation. In the case of SRC-2, we previously demonstrated that increasing the levels of this coregulator results in severe uterine dysfunction in the mouse [29] , resulting in a striking subfertility phenotype. The uterine defects resulting from increased SRC-2 levels include a marked impairment in uterine decidualization and an enhanced proliferative response to E2 exposure leading to endometrial glandular cysts and epithelial hyperplasia [29] . In view of the strengthening link between SPOP somatic mutations and a subset of human endometrial cancers [2] [3] [4] [5] 
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